Benevolent Platform

by BenevolentAI

AI-enabled drug discovery and development

London, United Kingdom201-500 employeesFounded 2013Updated 12/10/2025

4.2

Based on 0 reviews

Visit Website

About

BenevolentAI operates an AI platform that integrates biomedical data to generate target and drug hypotheses.

User Reviews

0 reviews • Average rating: 4.2/5

Write a Review

Governance Score

/100

Good

Calculated from verified certifications, user reviews, and compliance assessments. This score helps regulated industries evaluate AI tools for security, transparency, fairness, privacy, and accountability.

Industries

Pharmaceutical

Pricing

Contact sales

Related Tools

Tempus

Verified

Tempus Labs, Inc.

4.5

0 reviews

AI-enabled precision medicine

HIPAAGDPR

Chicago, IL, USA1000+ employees

PathAI

Verified

PathAI, Inc.

4.4

0 reviews

AI-powered pathology for drug development

ISO 27001HIPAA

Boston, MA, USA201-500 employees

Unlearn

Verified

Unlearn.AI, Inc.

4.3

0 reviews

TwinR trials for AI-enhanced clinical studies

ISO 27001

San Francisco, CA, USA51-200 employees